The neurosurgeon leading the trial tells Sky News the level of control the Neuralink chip offers is “mindblowing” and will be a “game-changer”
One of the most-viewed PNAS articles in the last week is “Quantifying the compressibility of the human brain.” Explore the article here: https://ow.ly/jGEu50Y6heQ
For more trending articles, visit https://ow.ly/FjuI50Y6heP.
In the human brain, the allowed patterns of activity are constrained by the correlations between brain regions. Yet it remains unclear which correlations—and how many—are needed to predict large-scale neural activity. Here, we present an information-theoretic framework to identify the most important correlations, which provide the most accurate predictions of neural states. Applying our framework to cortical activity in humans, we find that the vast majority of variance in activity is explained by a small number of correlations. This means that the brain is highly compressible: Only a sparse network of correlations is needed to predict large-scale activity. We find that this compressibility is strikingly consistent across different individuals and cognitive tasks and that, counterintuitively, the most important correlations are not necessarily the strongest.
A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer. The findings, published November 10 in Cell Reports, reveal how differences among cells within a single tumor influence the cancer’s response to chemotherapy, and introduce a promising new therapy designed to tip the odds in the patients’ favor.
Glioblastoma is notoriously difficult to treat. One of the key reasons is that no two cells within the tumor behave exactly alike. Even inside one tumor, some cells may respond to treatment while others resist it, allowing the cancer to persist and grow. For decades, scientists have known that tumors are composed of diverse cells, but the biological forces driving these differences, and their impact on treatment, have remained elusive.
“Traditionally, researchers have focused on the overall behavior of a tumor by studying the average response across all the individual cells, using differences between the cells to interpret the average,” said senior author Clark Chen, MD, PhD, professor and director of the brain tumor program, department of neurosurgery at Brown University Health. “Our study fundamentally flipped that approach. Rather than focusing on the average response, we focused on the differences between individual cells within the same tumor, and what we found could change how we treat glioblastoma.”
The sensory proteins that control the motion of bacteria constantly fluctuate. AMOLF researchers, together with international collaborators from ETH Zurich and University of Utah, found out that these proteins can jointly switch on and off at the same time. The researchers discovered that this protein network operates at the boundary between order and disorder. The findings are published in Nature Physics on January 29.
Bacteria may be simple, single-celled organisms, but they still have a surprisingly sophisticated way of sensing and responding to their environment. Tom Shimizu, group leader at AMOLF and senior author of the study, explains that bacteria use networks of thousands of proteins to judge whether conditions are improving or worsening.
These mini brain organoids resemble the developing cortex — the area of our brains that think, feel and store memories.
This advancement will help us learn more about conditions like dementia, but what if we go too far and they become conscious?
Hear the full story on The world, the universe and us, a news podcast for the insatiably curious, hosted by Rowan Hooper and Penny Sarchet.
Tap link in bio to learn more
https://www.newscientist.com/podcasts/
While investigating the FGF21-oxytocin-dopamine system, a mechanism that regulates sugar appetite, a team of researchers at Kyoto University noticed reports suggesting that the protein FGF21 may regulate alcohol ingestion.
The team’s original aim had been to address sugar appetite in lifestyle-related diseases, but since alcohol is a fermented product of sugar, they speculated that perhaps the body contains a system that recognizes both alcohol and sugar as the same entity.
Alcohol consumption and intervention challenges Excessive alcohol consumption is a major global health issue, and effective countermeasures for prevention and treatment are limited. Patients with alcohol dependence generally have a low adherence to pharmaceuticals, and many avoid drug treatment because it deprives them of the pleasure of drinking.
If you name it, you can tame it. That’s a new tool for fighting cigarette cravings, according to assistant research psychologist Golnaz Tabibnia.
Her discovery, published in Neuropsychopharmacology, reveals that a technique she dubbed “cue labeling”—mentally naming the triggers that make you want to smoke—can reduce the subjective experience of craving and the brain activity associated with it.
“Name it to tame it! Putting feelings into words has long been known to calm emotions,” Tabibnia wrote on LinkedIn when announcing the publication. “Our latest paper shows that putting what we crave into words can help calm cravings.”